Barinthus Biotherapeutics plc (BRNS)
NASDAQ: BRNS · Real-Time Price · USD
0.610
-0.020 (-3.17%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Barinthus Biotherapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2019 |
| Net Income | -66.43 | -61.07 | -73.35 | 5.34 | -50.87 | Upgrade
|
| Depreciation & Amortization | 2.85 | 2.6 | 2.23 | 1.12 | 0.4 | Upgrade
|
| Other Amortization | 3 | 3.2 | 3.2 | 3.2 | 0.2 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.25 | - | - | -0.35 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 5.79 | 17.47 | - | - | - | Upgrade
|
| Stock-Based Compensation | 0.47 | 4.71 | 5.06 | 9.88 | 16.49 | Upgrade
|
| Other Operating Activities | 6.95 | 1.56 | 5.77 | -28.1 | 8.37 | Upgrade
|
| Change in Accounts Receivable | - | - | 5.8 | -5.83 | 0.56 | Upgrade
|
| Change in Accounts Payable | -2.2 | 0.9 | -3.38 | 1.14 | -3.53 | Upgrade
|
| Change in Unearned Revenue | -0.51 | 1.74 | - | -0.18 | -0.06 | Upgrade
|
| Change in Other Net Operating Assets | 2.35 | -0.04 | 3.75 | -0.65 | -4.15 | Upgrade
|
| Operating Cash Flow | -47.98 | -28.94 | -50.93 | -14.43 | -32.58 | Upgrade
|
| Capital Expenditures | -0.04 | -0.89 | -5.41 | -6.14 | -1.15 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.45 | - | - | 0.39 | - | Upgrade
|
| Cash Acquisitions | - | - | - | - | -11.77 | Upgrade
|
| Investing Cash Flow | 0.42 | -0.89 | -5.41 | -5.75 | -12.91 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | -0.16 | - | Upgrade
|
| Total Debt Repaid | - | - | - | -0.16 | - | Upgrade
|
| Net Debt Issued (Repaid) | - | - | - | -0.16 | - | Upgrade
|
| Issuance of Common Stock | 0 | 2.16 | 2.04 | 0.48 | 102.77 | Upgrade
|
| Other Financing Activities | - | - | -0.16 | - | -5.27 | Upgrade
|
| Financing Cash Flow | 0 | 2.16 | 1.87 | 0.33 | 222.74 | Upgrade
|
| Foreign Exchange Rate Adjustments | 7.01 | -2.02 | 2.17 | 0.19 | -6.46 | Upgrade
|
| Net Cash Flow | -40.55 | -29.69 | -52.3 | -19.67 | 170.79 | Upgrade
|
| Free Cash Flow | -48.02 | -29.83 | -56.34 | -20.57 | -33.73 | Upgrade
|
| Free Cash Flow Margin | - | -199.29% | -7024.69% | -46.01% | -12585.45% | Upgrade
|
| Free Cash Flow Per Share | -1.19 | -0.76 | -1.47 | -0.54 | -1.30 | Upgrade
|
| Cash Interest Paid | - | - | - | - | 1.84 | Upgrade
|
| Cash Income Tax Paid | - | - | - | - | 0.15 | Upgrade
|
| Levered Free Cash Flow | -28.04 | -16.29 | -42.35 | 1.64 | -16.54 | Upgrade
|
| Unlevered Free Cash Flow | -28.01 | -16.26 | -42.33 | 1.65 | -14.87 | Upgrade
|
| Change in Working Capital | -0.36 | 2.6 | 6.17 | -5.52 | -7.18 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.